Evidence map›Paper›PMID 34993650›Full record

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2022

Interventions to support adherence to oral anticancer therapies: research challenges, lessons learned, and strategies to overcome them from Australia and Switzerland.

Carole Bandiera, Xiomara Skrabal Ross, Evelina Cardoso, Dorothea Wagner, Chantal Csajka, Ian Olver, Pandora Patterson, Vijayaprakash Suppiah, Kate M Gunn, Marie Schneider

Abstract read
PubMed Publisher
In one paragraph

Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Carole BandieraSchool of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Rue Michel Servet 1, 1211, Geneva, Switzerland. Carole.Bandiera@unisante.ch.ORCID http://orcid.org/0000-0002-9996-3100
Xiomara Skrabal RossCancer Research Institute, University of South Australia, Adelaide, Australia.ORCID http://orcid.org/0000-0001-6748-3260
Evelina CardosoCenter for Research and Innovation in Clinical Pharmaceutical Sciences, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Dorothea WagnerDepartment of Oncology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Chantal CsajkaSchool of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Rue Michel Servet 1, 1211, Geneva, Switzerland.
Ian OlverSchool of Psychology, University of Adelaide, Adelaide, South Australia, Australia.
Pandora PattersonCanteen Australia, Research, Evaluation and Social Policy Unit, GPO Box 3821, Sydney, New South Wales, 2001, Australia.
Vijayaprakash SuppiahUniSA Clinical and Health Sciences, University of South Australia, Adelaide, Australia.
Kate M GunnDepartment of Rural Health, University of South Australia, Adelaide, Australia.
Marie SchneiderSchool of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Rue Michel Servet 1, 1211, Geneva, Switzerland.ORCID http://orcid.org/0000-0002-7557-9278
University of Geneva · CHUniversity of South Australia · AUUniversity of Lausanne · CHThe University of Adelaide · AUThe University of Sydney · AU

Funding

Swiss Cancer Research foundation HSR-4077-11-2016
6 · The paper itself

Abstract

Not monitoring adherence to oral anticancer therapies (OAT) can lead to poor clinical outcomes, including premature death as reported by Foulon et al. (Acta Clin Belg 66(2):85-96, 2011) and Greer et al. (Oncologist 21(3):354-76, 2016). Barriers to the implementation of supportive cancer care interventions in medication adherence occur with multiple hospital sites, cancer diagnoses, and numerous healthcare professionals. This commentary describes challenges and strategies from two OAT adherence trials in Australia and Switzerland to assist researchers in the design and implementation of future interprofessional trials.

Indexed as

Medication AdherenceNeoplasmsAdministration, OralAustraliaHealth PersonnelHumansSwitzerlandClinical trialsImplementation scienceMedication adherenceNeoplasmsOral anticancer therapies, Antineoplastic agentsPatient selection

Identifiers

PMID34993650
OpenAlexW4206731005

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.